Foscarnet: Difference between revisions
imported>David E. Volk m (→Chemistry) |
imported>David E. Volk m (→Chemistry) |
||
| Line 20: | Line 20: | ||
== Chemistry == | == Chemistry == | ||
Foscarnet is a [[carboxylic acid]]-based organic mimic of the natural inorganic compound [[pyrophosphate]]. The chemical name of foscarnet is phosphonoformic acid and it has chemical formula CH<sub>3</sub>O<sub>5</sub>P, giving it a molecular mass of 126.0053 g/mol. Being already phosphorylated, foscarnet does not need to be phosphorylated to become active. Becuase of this, viral strains resistant to [[acyclovir]] or [[ganciclovir]], associated with thymidine kinase deficiency, may be treatable with foscarnet. Foscarnet and related compounds, like [[phosphonoacetic acid]] (PAA), can be synthesized by reacting chloroformic acid esters with phosphites (the [[Arbuzov reaction]]) | Foscarnet is a [[carboxylic acid]]-based organic mimic of the natural inorganic compound [[pyrophosphate]]. The chemical name of foscarnet is phosphonoformic acid and it has chemical formula CH<sub>3</sub>O<sub>5</sub>P, giving it a molecular mass of 126.0053 g/mol. Being already phosphorylated, foscarnet does not need to be phosphorylated to become active. Becuase of this, viral strains resistant to [[acyclovir]] or [[ganciclovir]], associated with thymidine kinase deficiency, may be treatable with foscarnet. Foscarnet and related compounds, like [[phosphonoacetic acid]] (PAA), can be synthesized by reacting chloroformic acid esters with phosphites (the [[Arbuzov reaction]]).<ref>{{cite journal | author=Noren, Helgstrand, Johansson, Misiorny and Stening | title=Synthesis of esters of phosphonoformic acid and their antiherpes activity| journal=J. Med. Chem. |volume = 26 |issue=2 |pages=264-270 |year=1983|doi=|10.1021/jm00356a028 |url=http://pubs.acs.org/cgi-bin/archive.cgi/jmcmar/1983/26/i02/pdf/jm00356a028.pdf}}</ref> | ||
<ref>{{cite journal | author=Noren, Helgstrand, Johansson, Misiorny and Stening | title=Synthesis of esters of phosphonoformic acid and their antiherpes activity| journal=J. Med. Chem. |volume = 26 |issue=2 |pages=264-270 |year=1983|doi=|10.1021/jm00356a028 |url=http://pubs.acs.org/cgi-bin/archive.cgi/jmcmar/1983/26/i02/pdf/jm00356a028.pdf}}</ref> | |||
== Mechanism of action == | == Mechanism of action == | ||
Revision as of 14:20, 28 March 2008
|
| |||||||
| foscarnet | |||||||
| |||||||
| Uses: | treatment of CMV retinitis, herpes and HIV. | ||||||
| Properties: | antiviral agent | ||||||
| Hazards: | see drug interactions | ||||||
| |||||||
Foscarnet is an antiviral drug used to treat retinitis due to cytomegalovirus (CMV) and acyclovir-resistant herpes simplex virus (HSV-1 & HSV-2) infections in patients with compromised immune systems, often associated with AIDS.
Chemistry
Foscarnet is a carboxylic acid-based organic mimic of the natural inorganic compound pyrophosphate. The chemical name of foscarnet is phosphonoformic acid and it has chemical formula CH3O5P, giving it a molecular mass of 126.0053 g/mol. Being already phosphorylated, foscarnet does not need to be phosphorylated to become active. Becuase of this, viral strains resistant to acyclovir or ganciclovir, associated with thymidine kinase deficiency, may be treatable with foscarnet. Foscarnet and related compounds, like phosphonoacetic acid (PAA), can be synthesized by reacting chloroformic acid esters with phosphites (the Arbuzov reaction).[1]
Mechanism of action
Foscarnet binds to pyrophosphate binding sites of DNA polymerases and thus inhibits the production of viral DNA by blocking the energy source (pyrophosphate) from reaching the viral polymerases. Cellular DNA polymerases are not effected by the dosages at foscarnet is taken.
Synonyms and brand names
Synonyms
- Carboxyphosphonic acid
- Dihydroxyphosphinecarboxylic acid oxide
- Foscarnet sodium
- Forscarnet sodium
- hydroxycarbonyl phosponic acid
- PFA
- Phgosphonocarboxylic acid
- Phosphonoformate
- Phosphonoformic acid
Brand names
- Foscarmet®
- Foscavir®
- Triapten®
External links
- Foscarnet - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Template:MedMaster
- Template:DrugBank
References
- ↑ Noren, Helgstrand, Johansson, Misiorny and Stening (1983). "Synthesis of esters of phosphonoformic acid and their antiherpes activity". J. Med. Chem. 26 (2): 264-270. [e]